KPMG PARTNERS have been appointed administrators to Angel Biotechnology holdings and Angel Biomedical.
Blair Nimmo and Gary Fraser were appointed joint administrators on 8 February to the Scottish-based pharmaceutical manufacturing business.
Employing 22 staff across Glasgow, Edinburgh and Cramlington in Northumberland, all have been retained as the joint administrators look to find a buyer for the business. Shares in the AIM-listed business.
Negotiations had taken place between directors and two potential joint venture partners, however, these negotiations fell through, resulting in the administration.
Angel has suffered during tough trading conditions, incurring losses and facing cashflow problems.
Blair Nimmo, head of restructuring for KPMG in Scotland, said: “Angel Biotechnology and Angel Biomedical have worldwide reputations for the quality of their production facilities, understanding of global regulatory regimes, and being at the cutting edge of pharmaceutical and biotechnological manufacturing.
“We are hopeful that the companies, and their employees, will have a positive future given their unrivalled credentials and quality of service.”
The select committee heard that GT had not met up with the BHS pension scheme advisers or trustees, but had done so with Deloitte, Arcadia’s pension advisers
Mather boasts a quarter century of restructuring and insolvency experience gleaned across various roles at Deloitte and Begbies Traynor
Clothing firm behind Pretty Polly tights blames BHS for its collapse
BHS auditor PwC questioned over why it described the embattled retailer as a 'going concern' days before it was sold for £1